Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20053275HPVENSG00000169710.9protein_codingFASNNoNo2194P49327
TVIS44018068HTLV-1ENSG00000169710.9protein_codingFASNNoNo2194P49327
TVIS44051455HTLV-1ENSG00000169710.9protein_codingFASNNoNo2194P49327
TVIS44051456HTLV-1ENSG00000169710.9protein_codingFASNNoNo2194P49327
TCGA Plot Options
Drug Information
GeneFASN
DrugBank IDDB01034
Drug NameCerulenin
Target IDBE0000959
UniProt IDP49327
Regulation Typeinhibitor
PubMed IDs10102370; 11245456; 12181752; 11752352; 20373869; 17168665; 15878185
CitationsOskouian B, Saba JD: YAP1 confers resistance to the fatty acid synthase inhibitor cerulenin through the transporter Flr1p in Saccharomyces cerevisiae. Mol Gen Genet. 1999 Mar;261(2):346-53.@@Li JN, Gorospe M, Chrest FJ, Kumaravel TS, Evans MK, Han WF, Pizer ES: Pharmacological inhibition of fatty acid synthase activity produces both cytostatic and cytotoxic effects modulated by p53. Cancer Res. 2001 Feb 15;61(4):1493-9.@@Heiligtag SJ, Bredehorst R, David KA: Key role of mitochondria in cerulenin-mediated apoptosis. Cell Death Differ. 2002 Sep;9(9):1017-25.@@Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.@@Flavin R, Peluso S, Nguyen PL, Loda M: Fatty acid synthase as a potential therapeutic target in cancer. Future Oncol. 2010 Apr;6(4):551-62. doi: 10.2217/fon.10.11.@@Lupu R, Menendez JA: Pharmacological inhibitors of Fatty Acid Synthase (FASN)--catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents? Curr Pharm Biotechnol. 2006 Dec;7(6):483-93.@@Ronnett GV, Kim EK, Landree LE, Tu Y: Fatty acid metabolism as a target for obesity treatment. Physiol Behav. 2005 May 19;85(1):25-35.
GroupsExperimental
Direct Classification
SMILES[H][C@]1(O[C@]1([H])C(=O)CCC=CCC=CC)C(N)=O
Pathways
PharmGKBPA164764551
ChEMBLCHEMBL45627